Michael Hawley, Chairman
Active Needle Technology Ltd. is an innovative, pre-revenue medical device company. The company aims to address the universal problem of needle placement errors in ultrasound-guided needle interventional procedures through commercialisation of its award-winning “needle actuating device”, originally developed at the University of Dundee. The technology enables precision needle targeting and has the potential to allow clinicians to perform these procedures safely, efficiently and cost-effectively benefitting patients and healthcare providers.
The technology is the outcome of the research work carried out by Dr. Muhammad Sadiq, a biomedical engineer and RSE enterprise fellow, and Prof. Graeme McLeod, a consultant anaesthetist at Ninewells Hospital and the University of Dundee.
The adoption of Active Needle’s technology in clinical practice offers the potential of significant health economic and clinical benefits to drive shared value for investors, patients, clinicians and healthcare providers and payers.